James H. Holms
AbbVie (United States)(US)
Publications by Year
Research Areas
Synthesis and biological activity, Protease and Inhibitor Mechanisms, Peptidase Inhibition and Analysis, Synthesis and Biological Evaluation, Structural and Chemical Analysis of Organic and Inorganic Compounds
Most-Cited Works
- → 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation(1988)164 cited
- → Phenoxyphenyl SulfoneN-Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors(2001)103 cited
- → Hydroxamic acid inhibitors of 5-lipoxygenase(1987)86 cited
- → α-Keto amides as inhibitors of histone deacetylase(2003)81 cited
- → Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors(2017)64 cited
- → Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships(1990)54 cited
- → N-(Acyloxyalkyl)pyridinium Salts as Soluble Prodrugs of a Potent Platelet Activating Factor Antagonist(1994)54 cited
- → Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme(2001)52 cited
- → Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors(2001)52 cited
- → Expression and functional characterization of recombinant human HDAC1 and HDAC3(2004)45 cited